201 related articles for article (PubMed ID: 18037962)
1. The proline-rich domain in p63 is necessary for the transcriptional and apoptosis-inducing activities of TAp63.
Helton ES; Zhang J; Chen X
Oncogene; 2008 May; 27(20):2843-50. PubMed ID: 18037962
[TBL] [Abstract][Full Text] [Related]
2. The unique NH2-terminally deleted (DeltaN) residues, the PXXP motif, and the PPXY motif are required for the transcriptional activity of the DeltaN variant of p63.
Helton ES; Zhu J; Chen X
J Biol Chem; 2006 Feb; 281(5):2533-42. PubMed ID: 16319057
[TBL] [Abstract][Full Text] [Related]
3. DNA-binding and transactivation activities are essential for TAp63 protein degradation.
Ying H; Chang DL; Zheng H; McKeon F; Xiao ZX
Mol Cell Biol; 2005 Jul; 25(14):6154-64. PubMed ID: 15988026
[TBL] [Abstract][Full Text] [Related]
4. TAp63 and DeltaNp63 in cancer and epidermal development.
Candi E; Dinsdale D; Rufini A; Salomoni P; Knight RA; Mueller M; Krammer PH; Melino G
Cell Cycle; 2007 Feb; 6(3):274-85. PubMed ID: 17264681
[TBL] [Abstract][Full Text] [Related]
5. One, two, three--p53, p63, p73 and chemosensitivity.
Müller M; Schleithoff ES; Stremmel W; Melino G; Krammer PH; Schilling T
Drug Resist Updat; 2006 Dec; 9(6):288-306. PubMed ID: 17287142
[TBL] [Abstract][Full Text] [Related]
6. Novel in vivo targets of DeltaNp63 in keratinocytes identified by a modified chromatin immunoprecipitation approach.
Birkaya B; Ortt K; Sinha S
BMC Mol Biol; 2007 May; 8():43. PubMed ID: 17521434
[TBL] [Abstract][Full Text] [Related]
7. Frequent alteration of p63 expression in human primary bladder carcinomas.
Park BJ; Lee SJ; Kim JI; Lee SJ; Lee CH; Chang SG; Park JH; Chi SG
Cancer Res; 2000 Jul; 60(13):3370-4. PubMed ID: 10910040
[TBL] [Abstract][Full Text] [Related]
8. Cleavage of the transactivation-inhibitory domain of p63 by caspases enhances apoptosis.
Sayan BS; Sayan AE; Yang AL; Aqeilan RI; Candi E; Cohen GM; Knight RA; Croce CM; Melino G
Proc Natl Acad Sci U S A; 2007 Jun; 104(26):10871-6. PubMed ID: 17581882
[TBL] [Abstract][Full Text] [Related]
9. The promyelocytic leukaemia protein tumour suppressor functions as a transcriptional regulator of p63.
Bernassola F; Oberst A; Melino G; Pandolfi PP
Oncogene; 2005 Oct; 24(46):6982-6. PubMed ID: 16007146
[TBL] [Abstract][Full Text] [Related]
10. The C terminus of p53 family proteins is a cell fate determinant.
Harms KL; Chen X
Mol Cell Biol; 2005 Mar; 25(5):2014-30. PubMed ID: 15713654
[TBL] [Abstract][Full Text] [Related]
11. Properties of the six isoforms of p63: p53-like regulation in response to genotoxic stress and cross talk with DeltaNp73.
Petitjean A; Ruptier C; Tribollet V; Hautefeuille A; Chardon F; Cavard C; Puisieux A; Hainaut P; Caron de Fromentel C
Carcinogenesis; 2008 Feb; 29(2):273-81. PubMed ID: 18048390
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional activity of TAp63 promoter is regulated by c-jun.
Yao JY; Pao CC; Chen JK
J Cell Physiol; 2010 Nov; 225(3):898-904. PubMed ID: 20607803
[TBL] [Abstract][Full Text] [Related]
13. TRAF4 is potently induced by TAp63 isoforms and localised according to differentiation in SCCHN.
Gu X; Coates PJ; MacCallum SF; Boldrup L; Sjöström B; Nylander K
Cancer Biol Ther; 2007 Dec; 6(12):1986-90. PubMed ID: 18087216
[TBL] [Abstract][Full Text] [Related]
14. Complex transcriptional effects of p63 isoforms: identification of novel activation and repression domains.
Ghioni P; Bolognese F; Duijf PH; Van Bokhoven H; Mantovani R; Guerrini L
Mol Cell Biol; 2002 Dec; 22(24):8659-68. PubMed ID: 12446784
[TBL] [Abstract][Full Text] [Related]
15. A double dealing tale of p63: an oncogene or a tumor suppressor.
Chen Y; Peng Y; Fan S; Li Y; Xiao ZX; Li C
Cell Mol Life Sci; 2018 Mar; 75(6):965-973. PubMed ID: 28975366
[TBL] [Abstract][Full Text] [Related]
16. Tumor-derived mutations within the DNA-binding domain of p53 that phenotypically resemble the deletion of the proline-rich domain.
Roth J; Koch P; Contente A; Dobbelstein M
Oncogene; 2000 Mar; 19(14):1834-42. PubMed ID: 10777217
[TBL] [Abstract][Full Text] [Related]
17. p63 isoforms in triple-negative breast cancer: ΔNp63 associates with the basal phenotype whereas TAp63 associates with androgen receptor, lack of BRCA mutation, PTEN and improved survival.
Coates PJ; Nenutil R; Holcakova J; Nekulova M; Podhorec J; Svoboda M; Vojtesek B
Virchows Arch; 2018 Mar; 472(3):351-359. PubMed ID: 29484502
[TBL] [Abstract][Full Text] [Related]
18. DeltaNp73beta is active in transactivation and growth suppression.
Liu G; Nozell S; Xiao H; Chen X
Mol Cell Biol; 2004 Jan; 24(2):487-501. PubMed ID: 14701724
[TBL] [Abstract][Full Text] [Related]
19. p63 transcriptional regulation of epithelial integrity and cancer.
Trink B; Osada M; Ratovitski E; Sidransky D
Cell Cycle; 2007 Feb; 6(3):240-5. PubMed ID: 17297296
[TBL] [Abstract][Full Text] [Related]
20. Active transcription of the human FAS/CD95/TNFRSF6 gene involves the p53 family.
Schilling T; Schleithoff ES; Kairat A; Melino G; Stremmel W; Oren M; Krammer PH; Müller M
Biochem Biophys Res Commun; 2009 Sep; 387(2):399-404. PubMed ID: 19615968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
